Search Results 2671-2680 of 33503 for oral

  1. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    Oral prednisone ≥ 40 mg/day (or equivalent) or budesonide ≥ 9 mg/day or equivalent or beclomethasone ≥ 5 mg/day for at least 2 weeks;; Immunomodulators ...

  2. Difluprednate (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Difluprednate eye drops is used to treat eye pain, redness, and swelling caused by eye surgery. It is also used to treat an eye condition called endogenous ...

  3. A Study to Evaluate the Influence of Diet on GI Health - Mayo Clinic

    Use of oral corticosteroids and unable or unwilling to stop use of oral corticosteroids within the previous 6 weeks and for the duration of the study.

  4. Surgery - Doctors - Mayo Clinic

    Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Dental implant surgery, Jaw surgery, Maxillary osteotomy, Mandibular osteotomy, Mandibular ...

  5. Fecal Microbiota (Stool Clinical Trials - Mayo Clinic Research

    ... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...

  6. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep Medicine in Minnesota · Psychiatry and Psychology · Sleep Medicine ...

  7. Clinical Trials - The Influence of Diet on Gut Microbiotas

    Use of oral corticosteroids and unable or unwilling to stop use of oral corticosteroids within the previous 2 weeks and for the duration of the study.

  8. A Study to Evaluate the Effectiveness, Safety and Tolerability of Efgatigimod PH20 SC in Adults with Pemphigus - Mayo Clinic

    receiving a tapered dose of oral prednisone (or the equivalent), provided that prednisone has been given at stable dose ± a conventional immunosuppressant ...

  9. Rabih G. Tawk, M.D. - Doctors and Medical Staff - Mayo Clinic

    Professional memberships. 2022. ExaminerABNS Oral Board Examination. 2022. ExaminerABNS Oral Board Examination. 2022 - present. MemberContinuous Professional ...

  10. A Study Comparing Orteronel Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer, who have not had Chemotherapy - Mayo Clinic

    Continuous daily use of oral prednisone or oral dexamethasone for more than 14 days within 3 months prior to study; Received prior chemotherapy for prostate ...